169 related articles for article (PubMed ID: 36342581)
1. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
5. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
6. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
Peng F; Li H; You Q; Li H; Wu D; Jiang C; Deng G; Li Y; Li Y; Wu Y
Biomed Res Int; 2017; 2017():5019367. PubMed ID: 28386553
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
8. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Sun P; Li Y; Chang L; Tian X
Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta-analysis.
Huang M; Zhao Z; Yang L
Cancer Med; 2024 Apr; 13(8):e7200. PubMed ID: 38634194
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
16. Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients.
Gu X; Gao XS; Xiong W; Guo W; Han L; Bai Y; Peng C; Cui M; Xie M
Onco Targets Ther; 2016; 9():4805-13. PubMed ID: 27536144
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
Ding W; Tan Y; Qian Y; Xue W; Wang Y; Jiang P; Xu X
PLoS One; 2019; 14(10):e0223971. PubMed ID: 31618252
[TBL] [Abstract][Full Text] [Related]
19. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
